Literature DB >> 28236793

Complications and Cost Analysis of Intraoperative Arterial Complications in Head and Neck Free Flap Reconstruction.

Catherine S Chang1, Michael W Chu2, Jonas A Nelson1, Marten Basta3, Patrick Gerety2, Suhail K Kanchwala1, Liza C Wu1.   

Abstract

Background Microvascular anastomotic patency is fundamental to head and neck free flap reconstructive success. The aims of this study were to identify factors associated with intraoperative arterial anastomotic issues and analyze the impact on subsequent complications and cost in head and neck reconstruction. Methods A retrospective review was performed on all head and neck free flap reconstructions from 2005 to 2013. Patients with intraoperative, arterial anastomotic difficulties were compared with patients without. Postoperative outcomes and costs were analyzed to determine factors associated with microvascular arterial complications. A regression analysis was performed to control for confounders. Results Total 438 head and neck free flaps were performed, with 24 (5.5%) having intraoperative arterial complications. Patient groups and flap survival between the two groups were similar. Free flaps with arterial issues had higher rates of unplanned reoperations (p < 0.001), emergent take-backs (p = 0.034), and major surgical (p = 0.002) and respiratory (p = 0.036) complications. The overall cost of reconstruction was nearly double in patients with arterial issues (p = 0.001). Regression analysis revealed that African American race (OR = 5.5, p < 0.009), use of vasopressors (OR = 6.0, p = 0.024), end-to-side venous anastomosis (OR = 4.0, p = 0.009), and use of internal fixation hardware (OR =3.5, p = 0.013) were significantly associated with arterial complications. Conclusion Intraoperative arterial complications may impact complications and overall cost of free flap head and neck reconstruction. Although some factors are nonmodifiable or unavoidable, microsurgeons should nonetheless be aware of the risk association. We recommend optimizing preoperative comorbidities and avoiding use of vasopressors in head and neck free flap cases to the extent possible. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2017        PMID: 28236793     DOI: 10.1055/s-0037-1598618

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  5 in total

1.  Intraoperative and postanesthesia care unit fluid administration as risk factors for postoperative complications in patients with head and neck cancer undergoing free tissue transfer.

Authors:  Bryan J Dooley; Daniella Karassawa Zanoni; Marlena R Mcgill; Mahmoud I Awad; Jatin P Shah; Richard J Wong; Clara Broad; Babak J Mehrara; Ian Ganly; Snehal G Patel
Journal:  Head Neck       Date:  2019-10-08       Impact factor: 3.147

2.  Reconstruction with Free Flaps of Head and Neck Cancer Defects: A National Cohort Study.

Authors:  Giancarlo Buitrago; Felipe Caballero; Giovanni E Montealegre
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-08-19

Review 3.  The Use of Vasopressor Agents in Free Tissue Transfer for Head and Neck Reconstruction: Current Trends and Review of the Literature.

Authors:  Akash N Naik; Taylor Freeman; Michael M Li; Scarlett Marshall; Akina Tamaki; Enver Ozer; Amit Agrawal; Stephen Y Kang; Matthew O Old; Nolan B Seim
Journal:  Front Pharmacol       Date:  2020-08-28       Impact factor: 5.810

4.  Effects of endothelial defects and venous interposition grafts on the acute incidence of thrombus formation within microvascular procedures.

Authors:  Andreas M Fichter; Thomas Mücke; Lucas M Ritschl; Marie-Kristin Hofmann; Constantin T Wolff; Leonard H Schmidt; Klaus-Dietrich Wolff
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379

5.  Comparison of Hyperspectral Imaging and Microvascular Doppler for Perfusion Monitoring of Free Flaps in an In Vivo Rodent Model.

Authors:  Philipp Becker; Sebastian Blatt; Andreas Pabst; Diana Heimes; Bilal Al-Nawas; Peer W Kämmerer; Daniel G E Thiem
Journal:  J Clin Med       Date:  2022-07-16       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.